Preoperative anemia predicts poor outcome in surgically resected early-stage NSCLC patients

被引：0
|
作者：
Alexandra King
机构：
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷 / 10期
关键词：
D O I：
10.1038/ncponc0281
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 489
相关论文
共 50 条
  • [1] Lower Airway Microbiota Predicts Malignancy Recurrence of Surgically Resected Early-Stage Lung Cancer
    Kwok, B.
    Tsay, J. J.
    Sulaiman, I
    Wu, B. G.
    Li, Y.
    Pass, H., I
    Segal, L. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [2] Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma
    Farley, JH
    Hickey, KW
    Carlson, JW
    Rose, GS
    Kost, ER
    Harrison, TA
    CANCER, 2003, 97 (09) : 2196 - 2202
  • [3] Risk of Metastatic Spread in Patients With Early-Stage, Surgically Resected Pancreatic Neuroendocrine Tumors
    Strosberg, Jonathan
    Cheema, Asima
    Weber, Jill
    Coppola, Domenico
    Kvols, Larry
    PANCREAS, 2011, 40 (02) : 333 - 333
  • [4] Risk of Metastatic Spread in Patients with Early-Stage, Surgically Resected Pancreatic Neuroendocrine Tumors
    Strosberg, J.
    Cheema, A.
    Weber, J.
    Kvols, L.
    NEUROENDOCRINOLOGY, 2011, 94 : 47 - 47
  • [5] Histological and prognostic data on surgically resected early-stage lung adenocarcinoma
    Yotsukura, Masaya
    Asamura, Hisao
    Suzuki, Shigeki
    Asakura, Keisuke
    Yoshida, Yukihiro
    Nakagawa, Kazuo
    Sakurai, Hiroyuki
    Watanabe, Shun-ichi
    Motoi, Noriko
    DATA IN BRIEF, 2020, 31
  • [6] Low O-GlcNAcase Expression Is Associated with Poor Prognosis in Surgically Resected Early-Stage Lung Adenocarcinoma
    Wang, W.
    Ying, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S556 - S556
  • [7] Risk of metastatic spread in patients with early-stage, surgically resected pancreatic neuroendocrine tumors.
    Strosberg, J. R.
    Cheema, A.
    Weber, J.
    Kvols, L. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] Residual ctDNA after treatment predicts early relapse in patients with early-stage NSCLC.
    Gale, Davina
    Heider, Katrin
    Perry, Malcolm
    Marsico, Giovanni
    Ruiz-Valdepenas, Andrea
    Rundell, Viona
    Wulff, Jerome
    Sharma, Garima
    Howarth, Karen
    Gilligan, David
    Harden, Susan
    Rassl, Doris M.
    Rintoul, Robert
    Rosenfeld, Nitzan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer
    Ogawa, Makiko
    Tanaka, Atsushi
    Namba, Kei
    Shia, Jinru
    Wang, Julia Y.
    Roehrl, Michael H.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary
    Umezu, Tomokazu
    Shibata, Kiyosumi
    Kajiyama, Hiroaki
    Yamamoto, Eiko
    Nawa, Akihiro
    Kikkawa, Fumitaka
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (11) : 962 - 966
12345